(19)
(11) EP 2 220 097 A1

(12)

(43) Date of publication:
25.08.2010 Bulletin 2010/34

(21) Application number: 08848689.9

(22) Date of filing: 13.11.2008
(51) International Patent Classification (IPC): 
C07F 5/02(2006.01)
A61K 31/69(2006.01)
(86) International application number:
PCT/US2008/012706
(87) International publication number:
WO 2009/064414 (22.05.2009 Gazette 2009/21)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 13.11.2007 US 2797

(71) Applicant: Protez Pharmaceuticals, Inc.
Malvern, PA 19355 (US)

(72) Inventors:
  • BURNS, Christopher J.
    Malvern Pennsylvania 19355 (US)
  • JACKSON, Randy W.
    Glenmoore Pennsylvania 19343 (US)
  • GOSWAMI, Rajesh
    Upper Darby Pennsylvania 19082 (US)
  • XU, Hongyu
    Phoenixville Pennsylvania 19460 (US)

(74) Representative: von Sprecher, Georg 
Novartis Pharma AG Patent Department
4002 Basel
4002 Basel (CH)

   


(54) BETA-LACTAMASE INHIBITORS